Primum non nocere and "black box" warnings.

Suppr

超能文献

作者信息

Pearlman David S

出版信息

J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2.

DOI:10.1016/j.jaci.2005.09.030

PMID:16387580

Abstract

摘要

相似文献

Primum non nocere and "black box" warnings.

J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2.

Impact of recent black box warnings in the allergy world.

Ann Allergy Asthma Immunol. 2007 Oct;99(4):364-6. doi: 10.1016/S1081-1206(10)60554-6.

Black box warnings-implications in practice.

Geriatr Nurs. 2008 Nov-Dec;29(6):402-9. doi: 10.1016/j.gerinurse.2008.09.005.

"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.

J Allergy Clin Immunol. 2006 Jan;117(1):34-9. doi: 10.1016/j.jaci.2005.10.031.

"Black box" warning: wake-up call or overreaction?

J Allergy Clin Immunol. 2006 Jan;117(1):26-9. doi: 10.1016/j.jaci.2005.11.006.

Black box warnings: what do they mean to pharmacists and patients.

Consult Pharm. 2012 Jul;27(7):482-92. doi: 10.4140/TCP.n.2012.482.

The "black box" warning and allergy drugs.

J Allergy Clin Immunol. 2006 Jan;117(1):40-4. doi: 10.1016/j.jaci.2005.08.060.

FDA offers advice to reduce risks of long-acting beta-agonists in asthma care.

JAMA. 2010 Apr 14;303(14):1353-4. doi: 10.1001/jama.2010.357.

Thinking outside the (black) box: a new research agenda.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):387-9. doi: 10.1002/pds.1205.

Avoiding drug interactions.

Am Fam Physician. 2000 Mar 15;61(6):1628, 1630, 1637.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Primum non nocere and "black box" warnings.

J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2.

Impact of recent black box warnings in the allergy world.

Ann Allergy Asthma Immunol. 2007 Oct;99(4):364-6. doi: 10.1016/S1081-1206(10)60554-6.

Black box warnings-implications in practice.

Geriatr Nurs. 2008 Nov-Dec;29(6):402-9. doi: 10.1016/j.gerinurse.2008.09.005.

"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.

J Allergy Clin Immunol. 2006 Jan;117(1):34-9. doi: 10.1016/j.jaci.2005.10.031.

"Black box" warning: wake-up call or overreaction?

J Allergy Clin Immunol. 2006 Jan;117(1):26-9. doi: 10.1016/j.jaci.2005.11.006.

Black box warnings: what do they mean to pharmacists and patients.

Consult Pharm. 2012 Jul;27(7):482-92. doi: 10.4140/TCP.n.2012.482.

The "black box" warning and allergy drugs.

J Allergy Clin Immunol. 2006 Jan;117(1):40-4. doi: 10.1016/j.jaci.2005.08.060.

FDA offers advice to reduce risks of long-acting beta-agonists in asthma care.

JAMA. 2010 Apr 14;303(14):1353-4. doi: 10.1001/jama.2010.357.

Thinking outside the (black) box: a new research agenda.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):387-9. doi: 10.1002/pds.1205.

Avoiding drug interactions.

Am Fam Physician. 2000 Mar 15;61(6):1628, 1630, 1637.